美股A股
StockGist

Privia Health Group, Inc.

PRVANASDAQ · Healthcare · Medical - Healthcare Information Services
Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
$24.55+3.72%
报价 2026-11-13
市值
$3.14B
EV
$2.63B
PE (TTM)
86.2x
预期 PE (FY2026)
88.5x
52 周区间距高点 -12.6%
$19.10$28.10

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-13
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22027-121.1x0.37 → 0.44(1.2x)55.4
FY+32028-121.3x0.37 → 0.58(1.6x)42.4

毛利率 11% · TTM 收入 $2435M · 基数 EPS 0.37(调整后)

电话会信号

辅助标签
Q3 20262026-11-05
上调指引
指引 上调
信心 5
分析师 4

“We expect to reach 6,000 clinicians by year-end and adjusted EBITDA growth of 23.9% at the midpoint.”

原文引用(1)
  • 上调指引:we are raising our 2026 outlook above the high end of our initial guidance for all key financial metrics

蓝色标签在暴涨研究中略有区分度;悬停查看口径。

研究结论

L2 2026-07-02全文 ↓

尚未生成 L3 估值,没有三情景目标价。去生成估值 →

L2 报告格式无法提取要点,请看全文。

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
PRVAPrivia Health Group, Inc.$3.14B+3.7%+20.0%21%86.2x35.4x28.4x
LIVNLivaNova PLC$5.03B+1.2%+11.1%67.4%25.4x22.7x38.9xGARP
TVTXTravere Therapeutics, Inc.$4.86B-1.8%+54.0%94.4%–4103.2x705.8x
ICUIICU Medical, Inc.$4.48B+1.1%-0.8%36.4%90.1x20.0x52.4x
HTFLHeartflow, Inc. Common Stock$4.26B-19.1%+43.4%83.6%–––高增长
NVSTEnvista Holdings Corp$3.93B-0.7%+8.6%57.9%6.4x5.3x17.9xCheap
ARQTArcutis Biotherapeutics, Inc.$3.57B+2.7%+50.5%91.1%144.4x94.1x102.4x
PBHPrestige Consumer Healthcare Inc.$2.19B+1.9%+16.6%50%12.4x10.0x9.1xGARP
SUPNSupernus Pharmaceuticals, Inc.$1.73B+1.8%+26.8%85.7%8.0x3.4x55.3xCheap GARP
同行中位数––+21.7%75.5%18.9x20.0x52.4x

研究全文

财务报表

Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$657M$632.6M$603.8M$541.2M$580.4M$521.2M$480.1M$460.9M
Gross Margin21%1.9%9.4%9.2%10.5%9.1%9.5%10.4%
Operating Margin3.1%1.9%1.2%2.1%2.5%0.6%1.1%1.1%
Net Income$13.5M$9M$3.1M$9.2M$6.9M$2.7M$4.2M$4.4M
Diluted EPS0.10.070.020.070.050.020.030.03
Operating Cash Flow$28.9M$1.1M$-49.5M$127.5M$52M$8M$-24.1M$74.8M

研究材料